This refers to how an allosteric modulator affects signaling for a specific orthosteric agonist. Such as, an allosteric modulator may possibly change THC signaling, but not endogenous cannabinoid signaling. A vital potential endogenous adverse allosteric modulator for CB1 could be the steroid hormone, pregnenolone [forty–forty two]. Some (nevertheless not all https://insurance-claims-assistan91112.qowap.com/92119100/tetrahydrocannabinol-thc-an-overview